Source: Life Care News

Sebela Pharmaceuticals: Sebela Pharmaceuticals Acquires Exclusive Licensing Rights to Develop and Commercialize Tegoprazan in the U.S. and Canada

Continue reading Sebela Pharmaceuticals® Acquires Exclusive Licensing Rights to Develop and Commercialize Tegoprazan in the U.S. and Canada at Life Care News.

Read full article »
Sebela Pharmaceuticals's Competitors | Sebela Pharmaceuticals's News | Sebela Pharmaceuticals's Financials
Stay up-to-date with the latest news on Sebela Pharmaceuticals
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Alan Cooke's photo - President & CEO of Sebela Pharmaceuticals

President & CEO

Alan Cooke

CEO Approval Rating

82/100

Read more
Stay up-to-date with the latest news on Sebela Pharmaceuticals